188 related articles for article (PubMed ID: 17616113)
21. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility.
Ishikawa M; Hiraiwa Y; Kubota D; Tsushima M; Watanabe T; Murakami S; Ouchi S; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2131-50. PubMed ID: 16307881
[TBL] [Abstract][Full Text] [Related]
22. Design and chemical synthesis of integrin ligands.
Heckmann D; Kessler H
Methods Enzymol; 2007; 426():463-503. PubMed ID: 17697896
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
24. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives.
López-Rodríguez ML; Porras E; Morcillo MJ; Benhamú B; Soto LJ; Lavandera JL; Ramos JA; Olivella M; Campillo M; Pardo L
J Med Chem; 2003 Dec; 46(26):5638-50. PubMed ID: 14667218
[TBL] [Abstract][Full Text] [Related]
25. Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
Bioorg Med Chem; 2008 May; 16(10):5490-500. PubMed ID: 18455407
[TBL] [Abstract][Full Text] [Related]
26. Oligomerisation and thermal stability of polyvalent integrin alpha5beta1 ligands.
Kreiner M; Byron O; Domingues D; van der Walle CF
Biophys Chem; 2009 Jun; 142(1-3):34-9. PubMed ID: 19307051
[TBL] [Abstract][Full Text] [Related]
27. Selective imaging of the angiogenic relevant integrins α5β1 and αvβ3.
Neubauer S; Rechenmacher F; Beer AJ; Curnis F; Pohle K; D'Alessandria C; Wester HJ; Reuning U; Corti A; Schwaiger M; Kessler H
Angew Chem Int Ed Engl; 2013 Oct; 52(44):11656-9. PubMed ID: 24115324
[TBL] [Abstract][Full Text] [Related]
28. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonists.
Ishikawa M; Kubota D; Yamamoto M; Kuroda C; Iguchi M; Koyanagi A; Murakami S; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2109-30. PubMed ID: 16309912
[TBL] [Abstract][Full Text] [Related]
29. Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides.
Chan C; Borthwick AD; Brown D; Burns-Kurtis CL; Campbell M; Chaudry L; Chung CW; Convery MA; Hamblin JN; Johnstone L; Kelly HA; Kleanthous S; Patikis A; Patel C; Pateman AJ; Senger S; Shah GP; Toomey JR; Watson NS; Weston HE; Whitworth C; Young RJ; Zhou P
J Med Chem; 2007 Apr; 50(7):1546-57. PubMed ID: 17338508
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
31. Alpha-methyltryptamine sulfonamide derivatives as novel glucocorticoid receptor ligands.
Marshall DR; Rodriguez G; Thomson DS; Nelson R; Capolina A
Bioorg Med Chem Lett; 2007 Jan; 17(2):315-9. PubMed ID: 17118655
[TBL] [Abstract][Full Text] [Related]
32. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biochemical evaluation of novel alpha V beta 3 integrin ligands.
Marugan JJ; Haslow KD; Crysler C
Bioorg Med Chem Lett; 2004 Sep; 14(17):4553-5. PubMed ID: 15357991
[TBL] [Abstract][Full Text] [Related]
34. Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity.
Berardi F; Abate C; Ferorelli S; de Robertis AF; Leopoldo M; Colabufo NA; Niso M; Perrone R
J Med Chem; 2008 Dec; 51(23):7523-31. PubMed ID: 19053780
[TBL] [Abstract][Full Text] [Related]
35. N-Aryl-gamma-lactams as integrin alphavbeta3 antagonists.
Xi N; Arvedson S; Eisenberg S; Han N; Handley M; Huang L; Huang Q; Kiselyov A; Liu Q; Lu Y; Nunez G; Osslund T; Powers D; Tasker AS; Wang L; Xiang T; Xu S; Zhang J; Zhu J; Kendall R; Dominguez C
Bioorg Med Chem Lett; 2004 Jun; 14(11):2905-9. PubMed ID: 15125957
[TBL] [Abstract][Full Text] [Related]
36. Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.
Marinelli L; Lavecchia A; Gottschalk KE; Novellino E; Kessler H
J Med Chem; 2003 Oct; 46(21):4393-404. PubMed ID: 14521404
[TBL] [Abstract][Full Text] [Related]
37. ACE inhibitors hypothesis generation for selective design, synthesis and biological evaluation of 3-mercapto-2-methyl-propanoyl-pyrrolidine-3-imine derivatives as antihypertensive agents.
Ismail MA; Nabil Aboul-Enein M; Abouzid KA; Abou El Ella DA; Ismail NS
Bioorg Med Chem; 2009 May; 17(10):3739-46. PubMed ID: 19403313
[TBL] [Abstract][Full Text] [Related]
38. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
[TBL] [Abstract][Full Text] [Related]
39. 6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators.
Weiss JM; Jimenez HN; Li G; April M; Uberti MA; Bacolod MD; Brodbeck RM; Doller D
Bioorg Med Chem Lett; 2011 Aug; 21(16):4891-9. PubMed ID: 21757343
[TBL] [Abstract][Full Text] [Related]
40. Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies.
Di Fabio R; Arban R; Bernasconi G; Braggio S; Blaney FE; Capelli AM; Castiglioni E; Donati D; Fazzolari E; Ratti E; Feriani A; Contini S; Gentile G; Ghirlanda D; Sabbatini FM; Andreotti D; Spada S; Marchioro C; Worby A; St-Denis Y
J Med Chem; 2008 Nov; 51(22):7273-86. PubMed ID: 18975927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
